Free Trial

Precision BioSciences (DTIL) Stock Forecast & Price Target

$9.40
-0.37 (-3.79%)
(As of 06/21/2024 08:59 PM ET)

Precision BioSciences - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$46.33
392.91% Upside
High Forecast$60.00
Average Forecast$46.33
Low Forecast$19.00
TypeCurrent Forecast
6/25/23 to 6/24/24
1 Month Ago
5/26/23 to 5/25/24
3 Months Ago
3/27/23 to 3/26/24
1 Year Ago
6/25/22 to 6/25/23
Consensus Rating
Buy
Buy
Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$46.33$46.33$75.00$217.50
Forecasted Upside392.91% Upside257.88% Upside383.19% Upside508.00% Upside
Get Precision BioSciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for DTIL and its competitors with MarketBeat's FREE daily newsletter.

DTIL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

DTIL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Precision BioSciences Stock vs. The Competition

TypePrecision BioSciencesMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.70
2.50
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside392.91% Upside900.45% Upside10.90% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/30/2024HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$60.00 ➝ $60.00+389.00%
4/30/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$19.00+93.09%
7/28/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$180.00 ➝ $60.00+253.36%
3/13/2023BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform$210.00 ➝ $120.00+330.34%
8/9/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$90.00 ➝ $60.00+24.22%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 05:25 AM ET.

DTIL Forecast - Frequently Asked Questions

What is Precision BioSciences's stock forecast and purchase recommendation?

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Precision BioSciences is $46.33, with a high forecast of $60.00 and a low forecast of $19.00. The consensus rating for Precision BioSciences stock is Buy based on the current 3 buy ratings for DTIL. Learn more on DTIL's analyst rating history.

Do Wall Street analysts like Precision BioSciences more than its competitors?

Analysts like Precision BioSciences more than other "medical" companies. The consensus rating for Precision BioSciences is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how DTIL compares to other companies.

Does Precision BioSciences's stock price have much upside?

According to analysts, Precision BioSciences's stock has a predicted upside of 255.59% based on their 12-month stock forecasts.

What analysts cover Precision BioSciences?

Precision BioSciences has been rated by research analysts at Guggenheim, and HC Wainwright in the past 90 days.


Stock Forecasts and Research Tools

This page (NASDAQ:DTIL) was last updated on 6/24/2024 by MarketBeat.com Staff

From Our Partners